Threshold Impact
VC Fund
Edmonton, Canada
Threshold Impact is a VC fund in Edmonton focused on Health Care and Medical Device. Sustainable, Profitable Impact Investing in disruptive information technology, new media and medical innovations with passionate, capable social entrepreneurs.ThresholdImpact was founded to take on a brand new entrepreneurial challenge. We believe strongly in the power of free enterprise to enable sustainable, positive change.We mentor,consult/advise, and invest in disruptive innovations in information technology, new media and medical innovation with capable, passionate entrepreneurs – ideally with clear social goals. We seek socially responsible, sustainable, profitable ‘impact investments’. There’s a good description of the goals of impact investing here, at Wikipedia.Impact investment, or social entrepreneurship, can range from simply thinking about social goals in parallel along with the usual for-profit business goals, all the way to a dedicated focus on a social entrepreneurship portfolio with the social impact defined as the primary goal.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries Threshold Impact invests in
Stages Threshold Impact invests in
Countries Threshold Impact invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $571k–$5.5M
- Pre-Seed
- $281k–$1.5M
- Series A
- $5M–$15M
Investment Focus
Industry
- Health Care 12 (50%)
- Medical Device 8 (33%)
- Medical 5 (21%)
- Software 3 (13%)
- Artificial Intelligence 3 (13%)
Stage
- Seed 12 (50%)
- Pre-Seed 4 (17%)
- Series A 2 (8%)
- Venture - Series Unknown 1 (4%)
Country
- Canada 14 (58%)
- United States 2 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ray Muzyka
Founder and CEO
|
Founder and CEO | Total investments: 25 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Northernmost is a company that develops machines that protect and transport donated kidneys for transplantation. | $1.9M / Seed / Apr 03, 2025 | ||
| Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing itsown internal pipeline. | $5.5M / Seed / Feb 20, 2025 | ||
| Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health. | $570.5K / Seed / Oct 07, 2024 | ||
| B2B Proptech SaaS working with small and medium production home builders to help them sell more upgrades. | $1.2M / Seed / Jun 06, 2024 | ||
| PulseMedica, an Edmonton-based medical device startup, is developing an ophthalmic medical device platform for non-invasive, automated image-guided laser treatment enabled by 3D computer vision, real-time tracking, and femtosecond laser technology. PulseMedica is laser-focused on improving the quality of life for millions of people by buildingrevolutionary technology to image and treat vitreoretinal disease. PulseMedica’s short-term vision is to become the global expert in non-invasive, safe, effective screening and treatment of eye floaters, with the ultimate vision of becoming the global standard for screening and treating vitreoretinal disease. | $8.7M / Seed / May 29, 2024 | ||
| FluidAI Medical is a medical platform company at the forefront of revolutionizing global patient care, leveraging the transformative power of artificial intelligence in post-operative recovery. | $14.6M / Series A / Oct 10, 2023 | ||
| FluidAI Medical is a medical platform company at the forefront of revolutionizing global patient care, leveraging the transformative power of artificial intelligence in post-operative recovery. | $15M / Series A / Oct 10, 2023 | ||
| Nimble Science Ltd., a digital health company commercializing the first end-to-end GI intelligence platform using the SIMBA capsule for multi-omic mapping of the GI tract. | $2M / Seed / Apr 04, 2023 | ||
| Every hospital in the world is faced with a major challenge - the rising cost of heathcare - we want to do something about it. Arbutus Medical’s purpose is to develop a portfolio of “frugal innovation” devices that save costs for hospitals and improve access to orthopedic surgery for 5 million patients by 2030. Arbutus Medical's flagshipproduct is a radically affordable orthopaedic power tool system that is used in North American Trauma Centers, veterinary hospitals, military deployments, NGO missions, and hospitals in over 30 low- and middle-income countries worldwide. | $2.3M / Seed / Feb 13, 2023 | ||
| Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health. | $1.1M / Seed / Oct 07, 2022 | ||
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Threshold Impact invest in?
Threshold Impact invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Pre-Seed stage. Most of the 24 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Threshold Impact's check size?
Threshold Impact typically joins rounds of $571k–$5.5M at Seed, $281k–$1.5M at Pre-Seed and $5M–$15M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Threshold Impact participates in.
How do I contact Threshold Impact?
Public channels for Threshold Impact include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Threshold Impact?
The team at Threshold Impact includes Ray Muzyka (Founder and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
